--Wednesday,
April 26 |
- |
TCT
Asia Pacific : Featured Lectures |
- |
Drug
Eluting Stent Summit-I |
- |
Plenary
Sessions |
- |
Technical
Forum I: How to, What to
New Technique and Technology: CTO and AMI
Intervention |
- |
"What Makes
DES Effective and Safe?" – Cypher and
Endeavor Experience |
- |
Best Practice
in DES to Improve Clinical Outcome / Expect
More From Your DES |
- |
Management
Perspectives for the Prevention of Atherothrombotic
Events in ACS Patients |
- |
Optimal
Therapeutic Approach to Post PCI Patients |
- |
Angiomyogenesis
Symposium |
- |
Managing
the Vascular Puzzle of Cardiovascular Syndromes:
How Do We Integrate Science and Evidence into
Practice |
- |
Effects
of Statin on Inflammation & Latest Atherosclerosis
Trial |
--Thursday,
April 27 |
- |
Plenary Sessions |
- |
Late Breaking
Clinical Trials |
- |
Technical
Forum II: How to, What to
TRI Club - Evolving Paradigm |
- |
Technical
Forum III: How to, What to
New Horisons for Complex
Intervention |
- |
Hot
Topics I
Structural Heart Disease: Diagnosis and Interventional
Approaches |
- |
Hot
Topics II |
- |
Hot
Topics III
Lt. Main Interventions |
- |
APSIC
|
- |
CCT
The Retrograde Approach - Special Techniques
for CTOs from CCT Experts |
- |
EuroPCR
|
- |
Left
Main Intervention |
- |
Drug
Eluting Stent Summit II |
- |
Bifurcation
Lesion Intervention |
- |
Peripheral
Lesion Intervention: Ilio-popliteal Artery,
Infrapopliteal, SFA, Renal Artery |
- |
Complications |
- |
Cutting
Edge Strategies in ACS and ST Elevation MI |
- |
Trends &
Issues in Peripheral Cardiology |
- |
The New HEALING
Era with Genous |
- |
Optimizing the
Long-Term Prevention of Atherothrombotic Events |
- |
AMS: Continuity
in Proof of Concept |
- |
New Insights
and Therapeutic Approaches to Lipid Management |
- |
Crossing the
Lesion |
--Friday,
April 28 |
- |
Complex
Lesion Intervention: Atheroablation, Thrombectomy,
and Distal Protection |
- |
Noninvasive
Imaging Is Changing the Diagnostic Paradigm
for CAD: IVUS, CT, FFR |
- |
Chronic
Total Occlusions |
- |
Structural
Heart Disease - Congenital Valvular Disease,
PFO, ASD, and Perivalvular Leaks |
- |
Drug Eluting
Stent Summit III |
- |
Drug
Eluting Stent Summit - IV |
- |
Pathogenesis,
Detection, and Treatment of Vulnerable Plaque |
|
|
TCT
Asia Pacific : Featured Lectures |
|
Drug
Eluting Stent Summit-I |
|
Plenary
Sessions |
• |
The Preponderance of Data Favors CYPHER! |
|
-Lecturer : David R. Holmes, Jr, MD |
|
• |
Current Data Indicates No Clinically Relevant
Differences Between CYPHER and TAXUS! |
|
-Lecturer : Eberhard Grube, MD |
|
• |
New Aspects Treating Critical Limb Ischemia
|
|
-Lecturer : Dierk Scheinert, MD |
|
• |
Metallic
Biodegradeable Stent |
|
-Lecturer : Ron Waksman, MD |
|
• |
What
Can 2D IVUS Teach Us About Vulnerable Plaque? |
|
-Lecturer : Gary S. Mintz, MD |
|
• |
DES
Thrombosis: Is It Real and Is It Worse? New
Approaches to Solving It ? |
|
-Lecturer : David R. Holmes, Jr, MD |
|
• |
Virtual
Histology of AMI |
|
-Lecturer : Barry D. Rutherford, MD |
|
• |
Radiocontrast
Nephropathy: Still the Achilles' Heel of Interventional
Cardiology |
|
-Lecturer : Roxana Mehran, MD |
|
• |
Biolimus
A9 Drug-Eluting Stents: Technical Aspects
and a Comprehensive Review of the EU, Asia-Pacific,
and US NOBORI Clinical Trial Program |
|
-Lecturer : Eberhard Grube, MD |
|
• |
Carotid
Stenting |
|
-Lecturer : John R. Laird, Jr, MD |
|
|
Technical
Forum I: How to, What to ---New
Technique and Technology: CTO and AMI Intervention |
|
Management
Perspectives for the Prevention of Atherothrombotic
-- Events in ACS
Patients |
|
Optimal
Therapeutic Approach to Post PCI Patients |
|
Angiomyogenesis
Symposium |
|
Managing
the Vascular Puzzle of Cardiovascular Syndromes:
How Do We Integrate Science and Evidence into Practice |
|
Effects
of Statin on Inflammation & Latest Atherosclerosis
Trial |
|
Technical
Forum III: How to, What to ---New
Horisons for Complex Intervention |
|
Hot
Topics I --Structural
Heart Disease: Diagnosis and Interventional Approaches |
|
Hot
Topics II |
|
Hot
Topics III |
|
APSIC |
|
EuroPCR |
|
Left
Main Intervention |
|
Drug
Eluting Stent Summit II |
|
Bifurcation
Lesion Intervention |
|
Peripheral
Lesion Intervention: Ilio-popliteal Artery, Infrapopliteal,
SFA, Renal Artery |
|
Complications
|
|
Cutting
Edge Strategies in ACS and ST Elevation MI |
|
Complex
Lesion Intervention: Atheroablation, Thrombectomy,
and Distal Protection |
|
Noninvasive
Imaging Is Changing the Diagnostic Paradigm for
CAD: IVUS, CT, FFR |
|
Chronic
Total Occlusions |
|
Structural
Heart Disease - Congenital Valvular Disease, PFO,
ASD, and Perivalvular Leaks |
|
Drug
Eluting Stent Summit - IV |
|
Pathogenesis,
Detection, and Treatment of Vulnerable Plaque |
|
|